Asselta, Rosanna http://orcid.org/0000-0001-5351-0619
Paraboschi, Elvezia Maria
Stravalaci, Matteo http://orcid.org/0000-0002-5636-4204
Invernizzi, Pietro http://orcid.org/0000-0003-3262-1998
Bonfanti, Paolo
Biondi, Andrea
Pagani, Isabel
Pedotti, Mattia
Doni, Andrea
Scavello, Francesco
Mapelli, Sarah N. http://orcid.org/0000-0002-0129-2055
Sironi, Marina
Perucchini, Chiara
Varani, Luca http://orcid.org/0000-0002-0963-0987
Matkovic, Milos
Cavalli, Andrea
Cesana, Daniela http://orcid.org/0000-0001-6366-4224
Gallina, Pierangela
Pedemonte, Nicoletta
Capurro, Valeria
Clementi, Nicola http://orcid.org/0000-0002-1822-9861
Mancini, Nicasio
Bayarri-Olmos, Rafael http://orcid.org/0000-0003-3202-9679
Garred, Peter http://orcid.org/0000-0002-2876-8586
Rappuoli, Rino http://orcid.org/0000-0002-8827-254X
Duga, Stefano http://orcid.org/0000-0003-3457-1410
Bottazzi, Barbara http://orcid.org/0000-0002-1930-9257
Uguccioni, Mariagrazia
Vicenzi, Elisa http://orcid.org/0000-0003-0051-3968
Mantovani, Alberto http://orcid.org/0000-0001-5578-236X
Garlanda, Cecilia http://orcid.org/0000-0002-1510-7703
Funding for this research was provided by:
Ministero della Salute (COVID-2020-12371640, COVID-2020-12371640)
philantropic donation by Dolce & Gabbana fashion house
Banca Intesa San Paolo
Ministero dell’Istruzione, dell’Università e della Ricerca
Department of Excellence project PREMIA (PREcision MedIcine Approach: bringing biomarker research to clinic; AMAF Monza ONLUS; AIRCS
Fondazione Cariplo
Fondazione Cariplo
EC | Horizon 2020 Framework Programme (101003650)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A_182270)
Article History
Received: 9 March 2022
Accepted: 26 April 2022
First Online: 27 May 2022
Competing interests
: A.M., C.G. and B.B. are inventors of a patent (EP20182181) on PTX3 and obtain royalties on related reagents. A.M., C.G., B.B. and E.V. are inventors of two patents (102021000002738 and EP21214373.9) on MBL. R.R. is a full-time employee of the GSK group of companies. The other authors declare no competing interests.
Free to read: This content has been made available to all.